Proviron is a derivative of dihydrotestosterone. In clinical practice it is used to treat sexual dysfunction of various kinds, which are most often caused by a low level of endogenous testosterone. It can enhance potency and sexual interest and in some cases, increase the sperm count. The drug does not stimulate the production of testosterone by the body, its simply replaces its lack. Proviron has antiestrogenic activity, . prevents conversion of steroids into estradiol. The main use of proviron is that it greatly reduces sex hormone-binding globulin (SHBG), increasing the amount of free (bioavailable and active) testosterone in the blood. in fact, studies have shown that mesterolone is capable of binding to SHBG much stronger than any other steroid. Proviron as a derivative of dihydrotestosterone that can promote enhanced muscle hardness and density.
Oxandrolone (Anavar), is especially well suited with cutting cycle and many people is using for this purpose. By using Anavar you will not notice a big difference in gain of mass, but any mass that you gain it will be lean tissue. It is knowns as well as “Girl Steroid”. Female users are more likely to see gains in tissue. Using this steroid, it means that does not aromatize to estrogen, water retention is reported as quite law and gyno is not shown at all. After 5 days of administration of Anavar, there are noticeable results as 44% increase in muscle cell protein synthesis. Benefits of Anavar BD Max:· Doesn’t aromatize· Water retention is law· Liver toxic less than other drugs· Fat burningSpecification:· Active Life - 8-12 hours· Average Dose - 15-60 mg/daily· Aromatization - No..
After the Kefauver Harris Amendment was passed in 1962, the . FDA began the DESI review process to ensure the safety and efficacy of drugs approved under the more lenient pre-1962 standards, including Dianabol.  In 1965, the FDA pressured CIBA to further document its legitimate medical uses, and re-approved the drug for treating post-menopausal osteoporosis and pituitary-deficient dwarfism .  After CIBA's patent exclusivity period lapsed, other manufacturers began to market generic metandienone in the .